ci 988 has been researched along with 1-(3-chlorophenyl)piperazine in 2 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (1-(3-chlorophenyl)piperazine) | Trials (1-(3-chlorophenyl)piperazine) | Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 833 | 142 | 87 |
| Protein | Taxonomy | ci 988 (IC50) | 1-(3-chlorophenyl)piperazine (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA | 1 |
| Charney, DS; Goddard, AW; Goodman, WK; Heninger, GR; Money, R; Pande, AC; Price, LH; Woods, SW | 1 |
1 trial(s) available for ci 988 and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder.
Topics: Adult; Affect; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Blood Pressure; Female; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Indoles; Male; Meglumine; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Serotonin Receptor Agonists | 1999 |
1 other study(ies) available for ci 988 and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine | 1994 |